BICO Group AB (publ) CLLKF

CLLKF Company Overview

BICO Group AB (publ), traded in the U.S. on the OTC market under the ticker BCCOY, is a Sweden-based life science tools and biotechnology company focused on bioconvergence technologies. The company develops and supplies instruments, software, consumables, and laboratory solutions used in areas including 3D bioprinting, cell biology, diagnostics, genomics, and laboratory automation. BICO operates across the broader life sciences and biotech tools industries, serving pharmaceutical companies, biotechnology firms, academic institutions, and research laboratories. Its revenue is primarily generated through the sale of laboratory instruments, consumables, software platforms, and related services.

The company was founded in 2016 under the name CELLINK by Erik Gatenholm, Hector Martinez, and Valentin Vicente, initially focusing on bioinks and 3D bioprinting technologies. Through a series of acquisitions and expansions into adjacent life science technologies, the company rebranded to BICO Group in 2021 to reflect a broader strategic focus on bioconvergence. BICO has positioned itself as an integrated provider of advanced laboratory technologies by combining engineering, automation, software, and biology-focused capabilities across multiple research workflows.